Skip to content

A clinical study on the effect of Yinhua Miyanling Tablet on the formation of bacterial biofilm in ureteral stents and the evaluation of patients urinary tract symptoms during indwelling ureteral stents.

A clinical study on the effect of Yinhua Miyanling Tablet on the formation of bacterial biofilm in ureteral stents and the evaluation of patients urinary tract symptoms during indwelling ureteral stents.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041399
Enrollment
Unknown
Registered
2020-12-25
Start date
2019-03-24
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis

Interventions

Sponsors

Beijing Tongren Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The subject or his/her agent voluntary signing of informed consent; 2. Aged range on 18-65 years; 3. Urine culture for patients if the operation is confirm performed, and the urine culture is negative within one week before the operation; 4. No fever and other symptoms of systemic infection within two weeks before the surgery; 5. Non-complex stone patients with stone diameter <= 2cm ; operation time <= 1 hour; unilateral surgical catheter; 6. Patients with primary catheterization undergo surgery in the second phase; 7. No urinary tract obstruction after surgery; 8. The position of the ureteral stent tube using KUB on the second day after surgery was judged to be generally normal by the researcher.

Exclusion criteria

Exclusion criteria: 1. The patients who need antibiotics during the postoperative period (excluding routine preventive antibiotics during perioperative period); 2. Patients with diseases affecting their immunity or systemic status, such as hypoproteinemia, cardiovascular and cerebrovascular, liver, kidney or hematopoietic diseases, uncontrolled malignant tumor patients and mental patients (Patients with a laboratory index exceeding 1.5 times than the normal value are considered abnormal and clinically significant, according to the actual situation of each subject, the researcher decides whether to join the group); 3. Women who have been pregnant or breast-feeding, or women who plan to have a pregnancy within three months after extubation; 4. Those who cannot comply with the test plan.

Design outcomes

Primary

MeasureTime frame
Blood routine;Blood chemistry;Urine routine;Urine culture;

Countries

China

Contacts

Public ContactShan Chen

Beijing Tongren Hospital, Capital Medical University

shanchentr@gmail.com+86 13611257388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026